|
2024
|
Invention
|
Pharmaceutical composition.
The invention concerns pharmaceutical compositions containing a hydr... |
|
|
Invention
|
Kras g12d inhibitors.
The present invention relates to compounds that inhibit KRas G12D. In part... |
|
|
Invention
|
Erk protein kinase inhibitors. The invention relates to compounds of Formula (I): and pharmaceuti... |
|
2023
|
Invention
|
Protein tyrosine phosphatase inhibitors.
Compounds of Formula I or a stereoisomer, tautomer, pro... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Her2 mutation inhibitors.
This invention relates to compounds of Formula (I):
This invention r... |
|
|
Invention
|
Pyrazolo[3,4-b]pyridine compounds as inhibitors of tam and met kinases.
Provided herein are comp... |
|
|
Invention
|
Kras g12c inhibitors.
The present invention relates to compounds that inhibit KRas G12C. In part... |
|
|
Invention
|
Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors. Provided herein are compo... |
|
|
Invention
|
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds.
Compounds useful in ... |
|
|
Invention
|
Crystalline salt form of a shp2 inhibitor. This invention relates to a crystalline anhydrous form... |
|
|
Invention
|
Hdac inhibitor oki-179 in combination with binimetinib for the treatment of cancer. A method of t... |
|
|
Invention
|
Polymorphs of arry-380, a selective her2 inhibitor and pharmaceutical compositions containing the... |
|
2022
|
Invention
|
Crystalline form of n-(2-chloro-3-((5-chloro-3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino)-4-f... |
|
|
Invention
|
Treatment of brain cancer.
Compounds for the treatment of brain cancer are provided herein. Phar... |
|
|
Invention
|
N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine ... |
|
|
Invention
|
Solid dispersions of a erb2 (her2) inhibitor.
A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a... |
|
|
Invention
|
Kras g12d inhibitors. Compounds that inhibit KRas G12D. In particular, compounds that inhibit the... |
|
|
Invention
|
Her2 mutation inhibitors. This invention relates to compounds of Formula (I): (I), and enantiomer... |
|
|
Invention
|
Pharmaceutical combinations.
Provided herein are pharmaceutical combinations comprising (a) a B-... |
|
|
Invention
|
Compounds for the treatment of braf-associated diseases and disorders. Provided herein are compou... |
|
|
Invention
|
Compounds and compositions as protein kinase inhibitors.
The invention provides a novel class of... |
|
|
Invention
|
Protein tyrosine phosphatase inhibitors. Compounds of Formula I or a stereoisomer, tautomer, prod... |
|
|
Invention
|
Crystalline form of a shp2 inhibitor.
This Invention relates to a hemihydrate crystalline form o... |
|
|
Invention
|
Crystalline form of a shp2 inhibitor. This invention relates to a hemihydrate crystalline form of... |
|
2021
|
Invention
|
Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors.
Provided herein are comp... |
|
|
Invention
|
Kras g12d inhibitors. The present invention relates to compounds that inhibit KRas G12D. In parti... |
|
|
Invention
|
Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors. Provided herein are compo... |
|
|
Invention
|
Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors.
The pres... |
|
|
Invention
|
Compounds and compositions as protein kinase inhibitors. The invention provides a novel class of ... |
|
|
Invention
|
Pyrazolo[3,4-b]pyridine compounds as inhibitors of tam and met kinases. 1 and G are as defined he... |
|
|
Invention
|
Substituted pyrimido[5,4-d]pyrimidines as her2 inhibitors. This invention relates to compounds of... |
|
|
Invention
|
Pharmaceutical composition. The invention concerns pharmaceutical compositions containing a hydro... |
|
|
Invention
|
Methods to treat cancer using (r)-n-(3-fluoro-4-((3-((1-hydroxypropan-2-yl)amino)-1h-pyrazolo[3,4... |
|
|
Invention
|
Kras g12d inhibitors.
The present invention relates to compounds that inhibit KRas G12D, In part... |
|
2020
|
P/S
|
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep... |
|
|
Invention
|
Kras g12d inhibitors. Compounds that inhibit KRas G12D; in particular, compounds that inhibit the... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of melanoma |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of Cancer. |
|
2019
|
Invention
|
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases. 2, L, Y, an... |
|
|
Invention
|
Fused heterocyclic compounds as ret kinase inhibitors. y, W, X, Y, Z, Ring A and (AA) have the me... |
|
2018
|
P/S
|
Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations f... |
|
|
P/S
|
Anti-infectives; anti-inflammatories; antibacterial
pharmaceuticals; antibiotics; antifungal pre... |
|
|
P/S
|
[ Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal pr... |
|
2017
|
P/S
|
Printed publications, namely, brochures, booklets and
teaching materials regarding the use of ph... |
|
|
P/S
|
Printed publications, namely, brochures, booklets and teaching materials regarding the use of pha... |
|
|
P/S
|
Anti-infectives; Anti-inflammatories; Anti-bacterials; Antibiotics; Antifungal preparations; Anti... |
|
2016
|
P/S
|
Anti-infectives; anti-inflammatories; antibiotics; systemic and topic anti-fungals; antivirals; c... |
|
|
P/S
|
[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal pr... |
|
2014
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namel... |
|
|
P/S
|
Pharmaceutical preparations. |
|
2008
|
P/S
|
Chemical reagents for scientific research use in drug delivery and design; chemicals in the natur... |
|
2000
|
P/S
|
Chemical reagents for scientific or medical research use in drug delivery and design; chemicals i... |
